AbbVie Inc (ABBV), Cracker Barrel Old Country Store, Inc. (CBRL): Second Quarter Update – My Perfect Dividend Portfolio

Page 1 of 2

So it’s time for the second quarter update for my Perfect Dividend Portfolio, which I began to put together back in December and completed in April. I must take a moment to brag a bit; my portfolio is doing exactly what I wanted, and I am totally happy.

Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL)

In this article, I’ll talk about how my three favorite companies are doing: Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL), Meredith Corporation (NYSE:MDP) Publishing, and Sunoco Logistics Partners L.P. (NYSE:SXL).

For more information about my portfolio selection strategy, please read
this article
.

Portfolio status and future plans

All of the companies scored at least 18 points on my rating system when I chose them. I will re-calculate their score once per quarter. Anything that drops below a 16 will be considered for replacement.

I am also keeping a close eye on the current yield. I intend to reinvest dividends once per quarter, after all ten companies have paid out, and I will reinvest in each company in the order in which I chose it, unless the company no longer scores at least an 18.

My portfolio as a whole is currently yielding 3.8%, with which I am very happy considering my minimum criterion is 3.0%. I’d like to keep the yield on the entire portfolio between 3.5% and 4.0%.

Based on current share prices, the portfolio is up 6%, and it has paid out 1.7% in dividends.

Individual Companies

Now, for a quick update on where the individual companies stand today:

My first selection was Abbott Laboratories (NYSE:ABT). Once the company split into two on January 3, I sold the Abbott shares (then yielding only 1.8%) and reinvested in AbbVie Inc (NYSE:ABBV) shares (then yielding 5.0%). AbbVie Inc (NYSE:ABBV) paid out its dividend on May 15. The company is currently trading at $42 per share, up 32% from where I bought it in December. AbbVie Inc (NYSE:ABBV)‘s rating is a mix of the Abbott Laboratories (NYSE:ABT) and AbbVie Inc (NYSE:ABBV) metrics, and it now scores a 20 on my scoring system.

While I acknowledge that AbbVie Inc (NYSE:ABBV) is a new company and separate from Abbott Laboratories (NYSE:ABT), I believe that the management team will attempt to continue the same dividend growth strategy that Abbott Laboratories (NYSE:ABT) has pursued. Should AbbVie Inc (NYSE:ABBV) prove to follow a different dividend growth strategy, I will assess and remove it from my portfolio when it becomes necessary.

Partnerre Ltd (NYSE:PRE)

was my second selection, and it paid a dividend on May 31. It is currently trading at $88, up 9% from where I purchased it. Partnerre Ltd (NYSE:PRE)’s dividend yield has dropped to 2.9%, and its score has dropped to 17, so I’m considering it for replacement next quarter.

Enterprise Products Partners L.P. (NYSE:EPD)

paid a dividend on May 7. It is trading at $59, up 21%. Enterprise Products Partners L.P. (NYSE:EPD) has a 15-year history of raising dividends, and a 5-year DGR of 5.7%. The partnership has increased its dividend twice so far this year; its second quarter dividend was an increase of 7% over the same quarter last year. However, the dividend metrics have softened since I chose it; I am considering it for replacement.

Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL)

continues to delight me. The company paid a dividend on May 6. It’s trading at $95, up 49%. Interestingly enough,
Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL)‘s robust share price growth was matched by a significant increase in its dividend (50%), so it is still yielding 3.3%, and it has improved to a 20 on my scoring system.


A blowout earnings report shows that management is definitely doing something right with this company.
Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) currently pays out a reasonable 38% of earnings, but an even lower 16% of free cash flow, which it actually increased by over 100% year-over-year. Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL)
seems to be doing everything right, and they are rewarding their shareholders as they should.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!